vs
Side-by-side financial comparison of AbbVie (ABBV) and Arcellx, Inc. (ACLX). Click either name above to swap in a different company.
AbbVie is the larger business by last-quarter revenue ($16.6B vs $1.7M, roughly 10047.2× Arcellx, Inc.). AbbVie runs the higher net margin — 10.9% vs -3513.4%, a 3524.3% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (10.0% vs -89.2%). AbbVie produced more free cash flow last quarter ($4.9B vs $-58.9M). Over the past eight quarters, AbbVie's revenue compounded faster (16.2% CAGR vs -79.5%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.
ABBV vs ACLX — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $16.6B | $1.7M |
| Net Profit | $1.8B | $-58.1M |
| Gross Margin | 72.6% | — |
| Operating Margin | 27.3% | -3850.2% |
| Net Margin | 10.9% | -3513.4% |
| Revenue YoY | 10.0% | -89.2% |
| Net Profit YoY | 8354.5% | -23.4% |
| EPS (diluted) | $1.02 | $-1.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $16.6B | $1.7M | ||
| Q3 25 | $15.8B | $4.9M | ||
| Q2 25 | $15.4B | $7.6M | ||
| Q1 25 | $13.3B | $8.1M | ||
| Q4 24 | $15.1B | $15.3M | ||
| Q3 24 | $14.5B | $26.0M | ||
| Q2 24 | $14.5B | $27.4M | ||
| Q1 24 | $12.3B | $39.3M |
| Q4 25 | $1.8B | $-58.1M | ||
| Q3 25 | $186.0M | $-55.8M | ||
| Q2 25 | $938.0M | $-52.8M | ||
| Q1 25 | $1.3B | $-62.3M | ||
| Q4 24 | $-22.0M | $-47.1M | ||
| Q3 24 | $1.6B | $-25.9M | ||
| Q2 24 | $1.4B | $-27.2M | ||
| Q1 24 | $1.4B | $-7.2M |
| Q4 25 | 72.6% | — | ||
| Q3 25 | 66.4% | — | ||
| Q2 25 | 71.8% | — | ||
| Q1 25 | 70.0% | — | ||
| Q4 24 | 70.9% | — | ||
| Q3 24 | 70.9% | — | ||
| Q2 24 | 70.9% | — | ||
| Q1 24 | 66.7% | — |
| Q4 25 | 27.3% | -3850.2% | ||
| Q3 25 | 12.1% | -1248.3% | ||
| Q2 25 | 31.7% | -777.4% | ||
| Q1 25 | 28.0% | -847.6% | ||
| Q4 24 | -9.9% | -348.2% | ||
| Q3 24 | 26.5% | -129.1% | ||
| Q2 24 | 27.6% | -127.8% | ||
| Q1 24 | 22.7% | -40.3% |
| Q4 25 | 10.9% | -3513.4% | ||
| Q3 25 | 1.2% | -1127.1% | ||
| Q2 25 | 6.1% | -698.6% | ||
| Q1 25 | 9.6% | -766.0% | ||
| Q4 24 | -0.1% | -308.4% | ||
| Q3 24 | 10.8% | -99.4% | ||
| Q2 24 | 9.5% | -99.3% | ||
| Q1 24 | 11.1% | -18.3% |
| Q4 25 | $1.02 | $-1.01 | ||
| Q3 25 | $0.10 | $-0.99 | ||
| Q2 25 | $0.52 | $-0.94 | ||
| Q1 25 | $0.72 | $-1.13 | ||
| Q4 24 | $-0.03 | $-0.87 | ||
| Q3 24 | $0.88 | $-0.48 | ||
| Q2 24 | $0.77 | $-0.51 | ||
| Q1 24 | $0.77 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.3B | $450.3M |
| Total DebtLower is stronger | $58.9B | — |
| Stockholders' EquityBook value | $-3.3B | $402.4M |
| Total Assets | $134.0B | $604.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.3B | $450.3M | ||
| Q3 25 | $5.7B | $461.4M | ||
| Q2 25 | $6.5B | $453.1M | ||
| Q1 25 | $5.2B | $543.3M | ||
| Q4 24 | $5.6B | $587.4M | ||
| Q3 24 | $7.3B | $574.3M | ||
| Q2 24 | $13.2B | $516.7M | ||
| Q1 24 | $18.1B | $573.9M |
| Q4 25 | $58.9B | — | ||
| Q3 25 | $63.0B | — | ||
| Q2 25 | $63.0B | — | ||
| Q1 25 | $64.5B | — | ||
| Q4 24 | $60.3B | — | ||
| Q3 24 | $58.5B | — | ||
| Q2 24 | $58.0B | — | ||
| Q1 24 | $63.8B | — |
| Q4 25 | $-3.3B | $402.4M | ||
| Q3 25 | $-2.6B | $440.8M | ||
| Q2 25 | $-183.0M | $392.2M | ||
| Q1 25 | $1.4B | $416.9M | ||
| Q4 24 | $3.3B | $454.8M | ||
| Q3 24 | $6.0B | $483.0M | ||
| Q2 24 | $6.8B | $487.2M | ||
| Q1 24 | $8.0B | $496.6M |
| Q4 25 | $134.0B | $604.0M | ||
| Q3 25 | $133.9B | $655.9M | ||
| Q2 25 | $137.2B | $619.1M | ||
| Q1 25 | $136.2B | $648.1M | ||
| Q4 24 | $135.2B | $711.3M | ||
| Q3 24 | $143.4B | $764.9M | ||
| Q2 24 | $141.9B | $734.3M | ||
| Q1 24 | $148.9B | $779.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 45.44× | — | ||
| Q4 24 | 18.15× | — | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | 8.56× | — | ||
| Q1 24 | 7.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.2B | $-58.2M |
| Free Cash FlowOCF − Capex | $4.9B | $-58.9M |
| FCF MarginFCF / Revenue | 29.4% | -3563.4% |
| Capex IntensityCapex / Revenue | 2.0% | 46.2% |
| Cash ConversionOCF / Net Profit | 2.87× | — |
| TTM Free Cash FlowTrailing 4 quarters | $17.8B | $-212.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.2B | $-58.2M | ||
| Q3 25 | $7.0B | $-49.2M | ||
| Q2 25 | $5.2B | $-39.7M | ||
| Q1 25 | $1.6B | $-63.1M | ||
| Q4 24 | $7.0B | $-46.0M | ||
| Q3 24 | $5.4B | $30.7M | ||
| Q2 24 | $2.3B | $-36.2M | ||
| Q1 24 | $4.0B | $-31.9M |
| Q4 25 | $4.9B | $-58.9M | ||
| Q3 25 | $6.6B | $-49.5M | ||
| Q2 25 | $4.9B | $-40.2M | ||
| Q1 25 | $1.4B | $-63.9M | ||
| Q4 24 | $6.8B | $-47.5M | ||
| Q3 24 | $5.2B | $28.4M | ||
| Q2 24 | $2.0B | $-39.5M | ||
| Q1 24 | $3.8B | $-38.3M |
| Q4 25 | 29.4% | -3563.4% | ||
| Q3 25 | 42.1% | -1000.3% | ||
| Q2 25 | 31.7% | -532.4% | ||
| Q1 25 | 10.5% | -786.4% | ||
| Q4 24 | 44.7% | -311.3% | ||
| Q3 24 | 35.9% | 109.2% | ||
| Q2 24 | 14.0% | -144.1% | ||
| Q1 24 | 31.3% | -97.7% |
| Q4 25 | 2.0% | 46.2% | ||
| Q3 25 | 2.4% | 6.0% | ||
| Q2 25 | 1.7% | 6.4% | ||
| Q1 25 | 1.8% | 9.6% | ||
| Q4 24 | 1.9% | 9.8% | ||
| Q3 24 | 1.7% | 8.8% | ||
| Q2 24 | 1.7% | 11.7% | ||
| Q1 24 | 1.6% | 16.4% |
| Q4 25 | 2.87× | — | ||
| Q3 25 | 37.76× | — | ||
| Q2 25 | 5.49× | — | ||
| Q1 25 | 1.27× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 2.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
